Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Factors Affecting Pulmonary Ventilation01:19

Factors Affecting Pulmonary Ventilation

Besides the pressure difference between the external environment and the lungs, the airflow rate and ease of pulmonary ventilation are also influenced by three other factors: surface tension of the fluid in the alveoli, compliance of the lungs, and airway resistance.
Alveolar Surface Tension
The alveolar fluid lines the luminal surface of the alveoli and exerts a force called surface tension. This force is caused by the polar water molecules in the liquid being more strongly attracted to each...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of selective digestive decontamination on the pangenome composition of ESBL-E. coli.

The Journal of antimicrobial chemotherapy·2026
Same author

Bayesian networks as prognostic models in oncology: a systematic review and recommendations for clinical practice.

BMJ oncology·2026
Same author

Phenotypic convergence and collateral susceptibility development in Pseudomonas aeruginosa under antibiotic exposure in ICU patients.

npj antimicrobials and resistance·2026
Same author

Serotype distribution and coverage by pneumococcal vaccines in hospitalised adults with pneumococcal pneumonia in Germany.

ERJ open research·2026
Same author

Failure to rescue the trial: lessons from a randomised antibiotic treatment trial in the acute care setting.

Trials·2026
Same author

Considerations raised during the regulatory and ethics review of platform clinical trials in infectious diseases.

Contemporary clinical trials communications·2026

Related Experiment Video

Updated: Jul 6, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Predicting pathogens causing ventilator-associated pneumonia using a Bayesian network model.

Stefan Visscher1, Elize M Kruisheer, Carolina A M Schurink

  • 1Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht, Utrecht, The Netherlands.

The Journal of Antimicrobial Chemotherapy
|April 9, 2008
PubMed
Summary
This summary is machine-generated.

This study shows a Bayesian network model accurately predicts microbial causes of ventilator-associated pneumonia (VAP) and guides appropriate antibiotic selection, improving patient care.

Related Experiment Videos

Last Updated: Jul 6, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Area of Science:

  • Medical Informatics
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • A validated Bayesian network (BN) model exists for diagnosing ventilator-associated pneumonia (VAP).
  • This study evaluates the BN model's ability to predict VAP's microbial causes and inform antibiotic selection.

Purpose of the Study:

  • To assess the performance of a Bayesian network model in predicting microbial pathogens responsible for VAP.
  • To determine the model's effectiveness in guiding appropriate antibiotic selection for VAP treatment.

Main Methods:

  • Pathogens were categorized into seven groups based on antibiotic susceptibility and epidemiology.
  • The BN model incorporated upper respiratory tract colonization, influenced by admission/ventilation duration, prior cultures, and antibiotic use.
  • A reference database of 153 VAP episodes and their microbial causes was utilized.

Main Results:

  • The best-performing BN model, incorporating all data, achieved high AUC values (0.859-0.929) for predicting specific pathogens.
  • The model correctly predicted pathogen groups in 85% of monobacterial and 63% of polymicrobial VAP cases.
  • Linking fixed antibiotic choices to predicted pathogens indicated 92% of VAP episodes would receive appropriate treatment.

Conclusions:

  • Bayesian network models significantly improve VAP pathogen prediction and antibiotic selection when incorporating colonization information.
  • The developed model demonstrates excellent performance for both pathogen identification and antibiotic choice.
  • Prospective external validation is recommended to confirm the model's generalizability and clinical utility.